(Q24236378)

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Inhaled nitric oxide for respiratory failure in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Incidence and short-term outcome of acute lung injury in mechanically ventilated children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Pediatric acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

The existence of publication bias and risk factors for its occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Uncertainty method improved on best-worst case analysis in a binary meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Pharmacological therapy for acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Acute respiratory failure in intensive care units. FINNALI: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

An expanded definition of the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Overcoming the limitations of current meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Incidence and outcomes of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Arcsine test for publication bias in meta-analyses with binary outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Nonventilatory interventions in the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Liposomal prostaglandin E sub 1 in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

Evaluation of prostaglandin E1 for prevention of respiratory failure in high risk trauma patients: A prospective clinical trial and correlation with plasma suppressive factors for neutrophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Continuous intraarterial measurement of oxygenation during aerosolized prostacyclin administration in severe respiratory failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Treatment of pain in sickle-cell crisis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Functional and metabolic activity of polymorphonuclear leukocytes from patients with adult respiratory distress syndrome: results of a randomized double-blind placebo-controlled study on the activity of prostaglandin E1

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Aerosolized prostacyclin. In search of the ideal pulmonary vasodilator

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Epidemiology of acute lung injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Quality-adjusted survival in the first year after the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021

Incidence and outcomes of pediatric acute lung injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733.PUB2

7 January 2021